• Join
  • Login
  • Contact

Search abstracts

Neurotoxicity caused by valacyclovir in patients with renal failure

  • At: 2004 FIP Congress in New Orleans (USA)
  • Type: Poster
  • By: MAO, Mao (Chang-Gung Memorial Hospital, Department of Pharmacy Services, Tao-yuan, China Taiwan)
  • Co-author(s): Hsieh (Chang-Gung Memorial Hospital, China Taiwan)
    Deng (Chang-Gung Memorial Hospital, China Taiwan)
  • Abstract:

    Valacyclovir is a prodrug of acyclovir. Neurotoxicity associated with acyclovir therapy was well documented especially to patients with chronic renal failure. Generally recommended dose of valacyclovir is 500 mg daily for ESRD patients with creatinine clearance less than 10 ml/min. We report two cases of herpes-zoster in which the administration


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses